Effect of Anti-IL-2Rα Antibody on IL-2-induced Jak/STAT Signaling-Reference-Cited by-同舟云学术

Effect of Anti-IL-2Rα Antibody on IL-2-induced Jak/STAT Signaling

Published:2002-01 Issue:1 Volume:2 Page:31-40
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Tkaczuk Jean,Yu Chao-Lan,Baksh Shairaz,Milford Edgar L.,Carpenter Charles B.,Burakoff Steven J.,McKay Dianne B.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-6143.2002.020107.x/fullpdf

Reference21 articles.

1. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization;Hatakeyama;Cell,1989

2. Effect of interleukin-2 on the expression of cell cycle genes in human T lymphocytes;Kaczmarek;Biochem Biophys Res Commun,1985

3. A humanized antibody that binds to the interleukin 2 receptor;Queen;Proc Natl Acad Sci,1989

4. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders;Junghans;Cancer Res,1990

5. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation;Kirkman;Transplantation,1991

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib attenuates acute rejection and can serve as an immune induction therapy in heart transplantation;Clinical Immunology;2023-12

2. STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis;BMC Immunology;2022-01-22

3. GP96 and SMP30 Protein Priming of Dendritic Cell Vaccination Induces a More Potent CTL Response against Hepatoma;Journal of Healthcare Engineering;2022-01-07

4. The JAK/STAT signaling pathway: from bench to clinic;Signal Transduction and Targeted Therapy;2021-11-26

5. The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer;British Journal of Haematology;2017-05-30